- Home
- WNC vs RLAY Comparison
WNC vs RLAY Comparison
Compare WNC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNC
- RLAY
- Stock Information
- Founded
- WNC 1985
- RLAY 2015
- Country
- WNC United States
- RLAY United States
- Employees
- WNC N/A
- RLAY N/A
- Industry
- WNC Construction/Ag Equipment/Trucks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WNC Industrials
- RLAY Health Care
- Exchange
- WNC Nasdaq
- RLAY Nasdaq
- Market Cap
- WNC 425.6M
- RLAY 490.3M
- IPO Year
- WNC 1991
- RLAY 2020
- Fundamental
- Price
- WNC $10.22
- RLAY $3.18
- Analyst Decision
- WNC Hold
- RLAY Strong Buy
- Analyst Count
- WNC 1
- RLAY 11
- Target Price
- WNC $14.00
- RLAY $18.40
- AVG Volume (30 Days)
- WNC 613.7K
- RLAY 1.6M
- Earning Date
- WNC 07-23-2025
- RLAY 08-05-2025
- Dividend Yield
- WNC 3.13%
- RLAY N/A
- EPS Growth
- WNC N/A
- RLAY N/A
- EPS
- WNC N/A
- RLAY N/A
- Revenue
- WNC $1,812,354,000.00
- RLAY $7,679,000.00
- Revenue This Year
- WNC N/A
- RLAY $14.31
- Revenue Next Year
- WNC $18.83
- RLAY N/A
- P/E Ratio
- WNC N/A
- RLAY N/A
- Revenue Growth
- WNC N/A
- RLAY N/A
- 52 Week Low
- WNC $6.78
- RLAY $1.78
- 52 Week High
- WNC $24.03
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- WNC 57.29
- RLAY 55.48
- Support Level
- WNC $10.20
- RLAY $2.98
- Resistance Level
- WNC $10.77
- RLAY $3.48
- Average True Range (ATR)
- WNC 0.43
- RLAY 0.25
- MACD
- WNC 0.11
- RLAY -0.00
- Stochastic Oscillator
- WNC 70.82
- RLAY 58.45
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).